Terumo BCT, Inc.

Terumo Blood and Cell Technologies operates as a prominent entity in the field of blood management, focusing on blood safety, therapeutic apheresis, cell therapy, and cell collections. The organization is dedicated to enhancing the capabilities of blood to provide greater benefits to patients. With a workforce exceeding 7,900 individuals, Terumo BCT is involved in the collection, processing, development, and distribution of blood and cell-based treatments, enabling healthcare providers to deliver high-quality care to more patients. The company emphasizes its commitment to innovation, aiming to unlock potential through the development of new therapies, ensuring a robust global blood supply, and fostering impactful partnerships. Terumo BCT also supports the healthcare sector by advancing automated manufacturing processes to facilitate the availability of novel cell and gene therapies, particularly in Latin America. Recent initiatives include the launch of the Reveos Automated Blood Processing System in the U.S. and collaborations with various organizations to enhance blood processing and cell culture technologies. Terumo BCT has a history of community engagement, celebrating 60 years of service in Colorado, and continues to contribute to research and advancements in healthcare.

Driving directions from: